Related references
Note: Only part of the references are listed.Angiogenesis is regulated by a novel mechanism:: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released
Joseph E. Italiano et al.
BLOOD (2008)
Platelet-associated PF-4 as a biomarker of early tumor growth
David Cervi et al.
BLOOD (2008)
Preanalytic influence of sample handling on SELDI-TOF serum protein profiles
John F. Timms et al.
CLINICAL CHEMISTRY (2007)
Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis
Nava Almog et al.
FASEB JOURNAL (2006)
A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype
GN Naumov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets
L Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang et al.
CANCER RESEARCH (2004)
Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis
GJ Caine et al.
ANNALS OF MEDICINE (2004)
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor
HK Kim et al.
EUROPEAN JOURNAL OF CANCER (2003)
Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist
L Ma et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Heterogeneity of angiogenic activity in a human liposarcoma: A proposed mechanism for no take of human tumors in mice
EG Achilles et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
